Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Unaudited)

v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 6,107,078 $ 4,399,726
Short-term investment 4,000,000
Interest receivable 53,082
Prepaid expenses and other current assets 1,382,558 1,614,956
Total current assets 7,489,636 10,067,764
Total assets 7,489,636 10,067,764
Current liabilities:    
Accounts payable and accrued expenses 1,251,744 1,559,011
Short-term notes payable, net of debt issuance costs 56,134 227,348
Total liabilities 1,307,878 1,786,359
Stockholders’ equity:    
Preferred stock, no par value; 50,000,000 shares authorized; 428,291 Series H and 7,488,692 Series F outstanding at March 31, 2026, and 429,291 Series H and 7,488,692 Series F outstanding at December 31, 2025.
Common stock, $0.001 par value; 350,000,000 shares authorized; 4,375,729 and 4,271,529 shares issued and outstanding at March 31, 2026, and December 31, 2025, respectively 4,375 4,271
Additional paid-in capital 235,007,285 234,905,793
Accumulated deficit (228,829,902) (226,628,659)
Total stockholders’ equity 6,181,758 8,281,405
Total liabilities and stockholders’ equity $ 7,489,636 $ 10,067,764